Industry Research Reports

Home > Reports > Service & Software > Global Biopharmaceutical Testing Services Market Research Report 2026

Global Biopharmaceutical Testing Services Market Research Report 2026

Industry: Service & Software

Published Date: 2026-04-21

Pages: 134 Pages

Report ld: 6571028

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global Biopharmaceutical Testing Services market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

Biopharmaceutical testing is a critical step in the development of a biosimilar. Analytical testing provides the information needed to produce a safe and effective biopharmaceutical product, and the efficacy or safety depends on a product’s critical quality attributes (CQA). Biopharmaceutical testing involves the development, validation, and execution of wide-ranging cGMP analytical strategies, from routine tests to the application of state-of-the-art instrumental analysis, such as mass spectrometry.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report delivers a comprehensive overview of the global Biopharmaceutical Testing Services market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Biopharmaceutical Testing Services. The Biopharmaceutical Testing Services market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Biopharmaceutical Testing Services market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Biopharmaceutical Testing Services manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

MARKET SEGMENTATION

By Company

Eurofins Scientific
SGS
Envigo
Exova Group
PPD Inc.
Pace Analytical Services
Intertek Group
DYNALABS
RD Laboratories
West Pharmaceutical Services
Polymer Solutions
Boston Analytical
Accuratus Labs
Microbac
ARLBioPharma
Lapuck Laboratories
BioScreen

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Raw Materials Testing
In-Process and Product Release Testing
Finished Pharmaceutical Products Testing
Environmental Samples
Others

Segment by Application

Hospitals
Clinics
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.

Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.

Chapter 3: Provides a detailed view of the competitive landscape for Biopharmaceutical Testing Services companies, covering revenue share, development plans, and mergers and acquisitions.

Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.

Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.

Chapter 12: Key findings and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Biopharmaceutical Testing Services Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Raw Materials Testing

1.2.3 In-Process and Product Release Testing

1.2.4 Finished Pharmaceutical Products Testing

1.2.5 Environmental Samples

1.2.6 Others

1.3 Market by Application

1.3.1 Global Biopharmaceutical Testing Services Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Biopharmaceutical Testing Services Market Perspective (2021–2032)

2.2 Global Biopharmaceutical Testing Services Growth Trends by Region

2.2.1 Global Biopharmaceutical Testing Services Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Biopharmaceutical Testing Services Historic Market Size by Region (2021–2026)

2.2.3 Biopharmaceutical Testing Services Forecasted Market Size by Region (2027–2032)

2.3 Biopharmaceutical Testing Services Market Dynamics

2.3.1 Biopharmaceutical Testing Services Industry Trends

2.3.2 Biopharmaceutical Testing Services Market Drivers

2.3.3 Biopharmaceutical Testing Services Market Challenges

2.3.4 Biopharmaceutical Testing Services Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Biopharmaceutical Testing Services Players by Revenue

3.1.1 Global Top Biopharmaceutical Testing Services Players by Revenue (2021–2026)

3.1.2 Global Biopharmaceutical Testing Services Revenue Market Share by Players (2021–2026)

3.2 Global Top Biopharmaceutical Testing Services Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Biopharmaceutical Testing Services Revenue

3.4 Global Biopharmaceutical Testing Services Market Concentration Ratio

3.4.1 Global Biopharmaceutical Testing Services Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical Testing Services Revenue in 2025

3.5 Global Key Players of Biopharmaceutical Testing Services Head Offices and Areas Served

3.6 Global Key Players of Biopharmaceutical Testing Services, Products and Applications

3.7 Global Key Players of Biopharmaceutical Testing Services, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Biopharmaceutical Testing Services Breakdown Data by Type

4.1 Global Biopharmaceutical Testing Services Historic Market Size by Type (2021–2026)

4.2 Global Biopharmaceutical Testing Services Forecasted Market Size by Type (2027–2032)

5 Biopharmaceutical Testing Services Breakdown Data by Application

5.1 Global Biopharmaceutical Testing Services Historic Market Size by Application (2021–2026)

5.2 Global Biopharmaceutical Testing Services Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Biopharmaceutical Testing Services Market Size (2021–2032)

6.2 North America Biopharmaceutical Testing Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Biopharmaceutical Testing Services Market Size by Country (2021–2026)

6.4 North America Biopharmaceutical Testing Services Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Biopharmaceutical Testing Services Market Size (2021–2032)

7.2 Europe Biopharmaceutical Testing Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Biopharmaceutical Testing Services Market Size by Country (2021–2026)

7.4 Europe Biopharmaceutical Testing Services Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Biopharmaceutical Testing Services Market Size (2021–2032)

8.2 Asia-Pacific Biopharmaceutical Testing Services Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Biopharmaceutical Testing Services Market Size by Region (2021–2026)

8.4 Asia-Pacific Biopharmaceutical Testing Services Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Biopharmaceutical Testing Services Market Size (2021–2032)

9.2 Latin America Biopharmaceutical Testing Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Biopharmaceutical Testing Services Market Size by Country (2021–2026)

9.4 Latin America Biopharmaceutical Testing Services Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Biopharmaceutical Testing Services Market Size (2021–2032)

10.2 Middle East & Africa Biopharmaceutical Testing Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Biopharmaceutical Testing Services Market Size by Country (2021–2026)

10.4 Middle East & Africa Biopharmaceutical Testing Services Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Eurofins Scientific

11.1.1 Eurofins Scientific Company Details

11.1.2 Eurofins Scientific Business Overview

11.1.3 Eurofins Scientific Biopharmaceutical Testing Services Introduction

11.1.4 Eurofins Scientific Revenue in Biopharmaceutical Testing Services Business (2021–2026)

11.1.5 Eurofins Scientific Recent Development

11.2 SGS

11.2.1 SGS Company Details

11.2.2 SGS Business Overview

11.2.3 SGS Biopharmaceutical Testing Services Introduction

11.2.4 SGS Revenue in Biopharmaceutical Testing Services Business (2021–2026)

11.2.5 SGS Recent Development

11.3 Envigo

11.3.1 Envigo Company Details

11.3.2 Envigo Business Overview

11.3.3 Envigo Biopharmaceutical Testing Services Introduction

11.3.4 Envigo Revenue in Biopharmaceutical Testing Services Business (2021–2026)

11.3.5 Envigo Recent Development

11.4 Exova Group

11.4.1 Exova Group Company Details

11.4.2 Exova Group Business Overview

11.4.3 Exova Group Biopharmaceutical Testing Services Introduction

11.4.4 Exova Group Revenue in Biopharmaceutical Testing Services Business (2021–2026)

11.4.5 Exova Group Recent Development

11.5 PPD Inc.

11.5.1 PPD Inc. Company Details

11.5.2 PPD Inc. Business Overview

11.5.3 PPD Inc. Biopharmaceutical Testing Services Introduction

11.5.4 PPD Inc. Revenue in Biopharmaceutical Testing Services Business (2021–2026)

11.5.5 PPD Inc. Recent Development

11.6 Pace Analytical Services

11.6.1 Pace Analytical Services Company Details

11.6.2 Pace Analytical Services Business Overview

11.6.3 Pace Analytical Services Biopharmaceutical Testing Services Introduction

11.6.4 Pace Analytical Services Revenue in Biopharmaceutical Testing Services Business (2021–2026)

11.6.5 Pace Analytical Services Recent Development

11.7 Intertek Group

11.7.1 Intertek Group Company Details

11.7.2 Intertek Group Business Overview

11.7.3 Intertek Group Biopharmaceutical Testing Services Introduction

11.7.4 Intertek Group Revenue in Biopharmaceutical Testing Services Business (2021–2026)

11.7.5 Intertek Group Recent Development

11.8 DYNALABS

11.8.1 DYNALABS Company Details

11.8.2 DYNALABS Business Overview

11.8.3 DYNALABS Biopharmaceutical Testing Services Introduction

11.8.4 DYNALABS Revenue in Biopharmaceutical Testing Services Business (2021–2026)

11.8.5 DYNALABS Recent Development

11.9 RD Laboratories

11.9.1 RD Laboratories Company Details

11.9.2 RD Laboratories Business Overview

11.9.3 RD Laboratories Biopharmaceutical Testing Services Introduction

11.9.4 RD Laboratories Revenue in Biopharmaceutical Testing Services Business (2021–2026)

11.9.5 RD Laboratories Recent Development

11.10 West Pharmaceutical Services

11.10.1 West Pharmaceutical Services Company Details

11.10.2 West Pharmaceutical Services Business Overview

11.10.3 West Pharmaceutical Services Biopharmaceutical Testing Services Introduction

11.10.4 West Pharmaceutical Services Revenue in Biopharmaceutical Testing Services Business (2021–2026)

11.10.5 West Pharmaceutical Services Recent Development

11.11 Polymer Solutions

11.11.1 Polymer Solutions Company Details

11.11.2 Polymer Solutions Business Overview

11.11.3 Polymer Solutions Biopharmaceutical Testing Services Introduction

11.11.4 Polymer Solutions Revenue in Biopharmaceutical Testing Services Business (2021–2026)

11.11.5 Polymer Solutions Recent Development

11.12 Boston Analytical

11.12.1 Boston Analytical Company Details

11.12.2 Boston Analytical Business Overview

11.12.3 Boston Analytical Biopharmaceutical Testing Services Introduction

11.12.4 Boston Analytical Revenue in Biopharmaceutical Testing Services Business (2021–2026)

11.12.5 Boston Analytical Recent Development

11.13 Accuratus Labs

11.13.1 Accuratus Labs Company Details

11.13.2 Accuratus Labs Business Overview

11.13.3 Accuratus Labs Biopharmaceutical Testing Services Introduction

11.13.4 Accuratus Labs Revenue in Biopharmaceutical Testing Services Business (2021–2026)

11.13.5 Accuratus Labs Recent Development

11.14 Microbac

11.14.1 Microbac Company Details

11.14.2 Microbac Business Overview

11.14.3 Microbac Biopharmaceutical Testing Services Introduction

11.14.4 Microbac Revenue in Biopharmaceutical Testing Services Business (2021–2026)

11.14.5 Microbac Recent Development

11.15 ARLBioPharma

11.15.1 ARLBioPharma Company Details

11.15.2 ARLBioPharma Business Overview

11.15.3 ARLBioPharma Biopharmaceutical Testing Services Introduction

11.15.4 ARLBioPharma Revenue in Biopharmaceutical Testing Services Business (2021–2026)

11.15.5 ARLBioPharma Recent Development

11.16 Lapuck Laboratories

11.16.1 Lapuck Laboratories Company Details

11.16.2 Lapuck Laboratories Business Overview

11.16.3 Lapuck Laboratories Biopharmaceutical Testing Services Introduction

11.16.4 Lapuck Laboratories Revenue in Biopharmaceutical Testing Services Business (2021–2026)

11.16.5 Lapuck Laboratories Recent Development

11.17 BioScreen

11.17.1 BioScreen Company Details

11.17.2 BioScreen Business Overview

11.17.3 BioScreen Biopharmaceutical Testing Services Introduction

11.17.4 BioScreen Revenue in Biopharmaceutical Testing Services Business (2021–2026)

11.17.5 BioScreen Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Biopharmaceutical Testing Services Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Raw Materials Testing

Table 3. Key Players of In-Process and Product Release Testing

Table 4. Key Players of Finished Pharmaceutical Products Testing

Table 5. Key Players of Environmental Samples

Table 6. Key Players of Others

Table 7. Global Biopharmaceutical Testing Services Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Biopharmaceutical Testing Services Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 9. Global Biopharmaceutical Testing Services Market Size by Region (US$ Million), 2021–2026

Table 10. Global Biopharmaceutical Testing Services Market Share by Region (2021–2026)

Table 11. Global Biopharmaceutical Testing Services Forecasted Market Size by Region (US$ Million), 2027–2032

Table 12. Global Biopharmaceutical Testing Services Market Share by Region (2027–2032)

Table 13. Biopharmaceutical Testing Services Market Trends

Table 14. Biopharmaceutical Testing Services Market Drivers

Table 15. Biopharmaceutical Testing Services Market Challenges

Table 16. Biopharmaceutical Testing Services Market Restraints

Table 17. Global Biopharmaceutical Testing Services Revenue by Players (US$ Million), 2021–2026

Table 18. Global Biopharmaceutical Testing Services Market Share by Players (2021–2026)

Table 19. Global Top Biopharmaceutical Testing Services Players by Tier (Tier 1, Tier 2, and Tier 3), based on Biopharmaceutical Testing Services Revenue, 2025

Table 20. Ranking of Global Top Biopharmaceutical Testing Services Companies by Revenue (US$ Million) in 2025

Table 21. Global 5 Largest Players Market Share by Biopharmaceutical Testing Services Revenue (CR5 and HHI), 2021–2026

Table 22. Global Key Players of Biopharmaceutical Testing Services, Headquarters and Area Served

Table 23. Global Key Players of Biopharmaceutical Testing Services, Products and Applications

Table 24. Global Key Players of Biopharmaceutical Testing Services, Date of General Availability (GA)

Table 25. Mergers and Acquisitions, Expansion Plans

Table 26. Global Biopharmaceutical Testing Services Market Size by Type (US$ Million), 2021–2026

Table 27. Global Biopharmaceutical Testing Services Revenue Market Share by Type (2021–2026)

Table 28. Global Biopharmaceutical Testing Services Forecasted Market Size by Type (US$ Million), 2027–2032

Table 29. Global Biopharmaceutical Testing Services Revenue Market Share by Type (2027–2032)

Table 30. Global Biopharmaceutical Testing Services Market Size by Application (US$ Million), 2021–2026

Table 31. Global Biopharmaceutical Testing Services Revenue Market Share by Application (2021–2026)

Table 32. Global Biopharmaceutical Testing Services Forecasted Market Size by Application (US$ Million), 2027–2032

Table 33. Global Biopharmaceutical Testing Services Revenue Market Share by Application (2027–2032)

Table 34. North America Biopharmaceutical Testing Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. North America Biopharmaceutical Testing Services Market Size by Country (US$ Million), 2021–2026

Table 36. North America Biopharmaceutical Testing Services Market Size by Country (US$ Million), 2027–2032

Table 37. Europe Biopharmaceutical Testing Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 38. Europe Biopharmaceutical Testing Services Market Size by Country (US$ Million), 2021–2026

Table 39. Europe Biopharmaceutical Testing Services Market Size by Country (US$ Million), 2027–2032

Table 40. Asia-Pacific Biopharmaceutical Testing Services Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 41. Asia-Pacific Biopharmaceutical Testing Services Market Size by Region (US$ Million), 2021–2026

Table 42. Asia-Pacific Biopharmaceutical Testing Services Market Size by Region (US$ Million), 2027–2032

Table 43. Latin America Biopharmaceutical Testing Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Latin America Biopharmaceutical Testing Services Market Size by Country (US$ Million), 2021–2026

Table 45. Latin America Biopharmaceutical Testing Services Market Size by Country (US$ Million), 2027–2032

Table 46. Middle East & Africa Biopharmaceutical Testing Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 47. Middle East & Africa Biopharmaceutical Testing Services Market Size by Country (US$ Million), 2021–2026

Table 48. Middle East & Africa Biopharmaceutical Testing Services Market Size by Country (US$ Million), 2027–2032

Table 49. Eurofins Scientific Company Details

Table 50. Eurofins Scientific Business Overview

Table 51. Eurofins Scientific Biopharmaceutical Testing Services Product

Table 52. Eurofins Scientific Revenue in Biopharmaceutical Testing Services Business (US$ Million), 2021–2026

Table 53. Eurofins Scientific Recent Development

Table 54. SGS Company Details

Table 55. SGS Business Overview

Table 56. SGS Biopharmaceutical Testing Services Product

Table 57. SGS Revenue in Biopharmaceutical Testing Services Business (US$ Million), 2021–2026

Table 58. SGS Recent Development

Table 59. Envigo Company Details

Table 60. Envigo Business Overview

Table 61. Envigo Biopharmaceutical Testing Services Product

Table 62. Envigo Revenue in Biopharmaceutical Testing Services Business (US$ Million), 2021–2026

Table 63. Envigo Recent Development

Table 64. Exova Group Company Details

Table 65. Exova Group Business Overview

Table 66. Exova Group Biopharmaceutical Testing Services Product

Table 67. Exova Group Revenue in Biopharmaceutical Testing Services Business (US$ Million), 2021–2026

Table 68. Exova Group Recent Development

Table 69. PPD Inc. Company Details

Table 70. PPD Inc. Business Overview

Table 71. PPD Inc. Biopharmaceutical Testing Services Product

Table 72. PPD Inc. Revenue in Biopharmaceutical Testing Services Business (US$ Million), 2021–2026

Table 73. PPD Inc. Recent Development

Table 74. Pace Analytical Services Company Details

Table 75. Pace Analytical Services Business Overview

Table 76. Pace Analytical Services Biopharmaceutical Testing Services Product

Table 77. Pace Analytical Services Revenue in Biopharmaceutical Testing Services Business (US$ Million), 2021–2026

Table 78. Pace Analytical Services Recent Development

Table 79. Intertek Group Company Details

Table 80. Intertek Group Business Overview

Table 81. Intertek Group Biopharmaceutical Testing Services Product

Table 82. Intertek Group Revenue in Biopharmaceutical Testing Services Business (US$ Million), 2021–2026

Table 83. Intertek Group Recent Development

Table 84. DYNALABS Company Details

Table 85. DYNALABS Business Overview

Table 86. DYNALABS Biopharmaceutical Testing Services Product

Table 87. DYNALABS Revenue in Biopharmaceutical Testing Services Business (US$ Million), 2021–2026

Table 88. DYNALABS Recent Development

Table 89. RD Laboratories Company Details

Table 90. RD Laboratories Business Overview

Table 91. RD Laboratories Biopharmaceutical Testing Services Product

Table 92. RD Laboratories Revenue in Biopharmaceutical Testing Services Business (US$ Million), 2021–2026

Table 93. RD Laboratories Recent Development

Table 94. West Pharmaceutical Services Company Details

Table 95. West Pharmaceutical Services Business Overview

Table 96. West Pharmaceutical Services Biopharmaceutical Testing Services Product

Table 97. West Pharmaceutical Services Revenue in Biopharmaceutical Testing Services Business (US$ Million), 2021–2026

Table 98. West Pharmaceutical Services Recent Development

Table 99. Polymer Solutions Company Details

Table 100. Polymer Solutions Business Overview

Table 101. Polymer Solutions Biopharmaceutical Testing Services Product

Table 102. Polymer Solutions Revenue in Biopharmaceutical Testing Services Business (US$ Million), 2021–2026

Table 103. Polymer Solutions Recent Development

Table 104. Boston Analytical Company Details

Table 105. Boston Analytical Business Overview

Table 106. Boston Analytical Biopharmaceutical Testing Services Product

Table 107. Boston Analytical Revenue in Biopharmaceutical Testing Services Business (US$ Million), 2021–2026

Table 108. Boston Analytical Recent Development

Table 109. Accuratus Labs Company Details

Table 110. Accuratus Labs Business Overview

Table 111. Accuratus Labs Biopharmaceutical Testing Services Product

Table 112. Accuratus Labs Revenue in Biopharmaceutical Testing Services Business (US$ Million), 2021–2026

Table 113. Accuratus Labs Recent Development

Table 114. Microbac Company Details

Table 115. Microbac Business Overview

Table 116. Microbac Biopharmaceutical Testing Services Product

Table 117. Microbac Revenue in Biopharmaceutical Testing Services Business (US$ Million), 2021–2026

Table 118. Microbac Recent Development

Table 119. ARLBioPharma Company Details

Table 120. ARLBioPharma Business Overview

Table 121. ARLBioPharma Biopharmaceutical Testing Services Product

Table 122. ARLBioPharma Revenue in Biopharmaceutical Testing Services Business (US$ Million), 2021–2026

Table 123. ARLBioPharma Recent Development

Table 124. Lapuck Laboratories Company Details

Table 125. Lapuck Laboratories Business Overview

Table 126. Lapuck Laboratories Biopharmaceutical Testing Services Product

Table 127. Lapuck Laboratories Revenue in Biopharmaceutical Testing Services Business (US$ Million), 2021–2026

Table 128. Lapuck Laboratories Recent Development

Table 129. BioScreen Company Details

Table 130. BioScreen Business Overview

Table 131. BioScreen Biopharmaceutical Testing Services Product

Table 132. BioScreen Revenue in Biopharmaceutical Testing Services Business (US$ Million), 2021–2026

Table 133. BioScreen Recent Development

Table 134. Research Programs/Design for This Report

Table 135. Key Data Information from Secondary Sources

Table 136. Key Data Information from Primary Sources

Table 137. Authors List of This Report

List of Figures

Figure 1. Biopharmaceutical Testing Services Picture

Figure 2. Global Biopharmaceutical Testing Services Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Biopharmaceutical Testing Services Market Share by Type: 2025 vs 2032

Figure 4. Raw Materials Testing Features

Figure 5. In-Process and Product Release Testing Features

Figure 6. Finished Pharmaceutical Products Testing Features

Figure 7. Environmental Samples Features

Figure 8. Others Features

Figure 9. Global Biopharmaceutical Testing Services Market Size by Application (US$ Million), 2021–2032

Figure 10. Global Biopharmaceutical Testing Services Market Share by Application: 2025 vs 2032

Figure 11. Hospitals Case Studies

Figure 12. Clinics Case Studies

Figure 13. Others Case Studies

Figure 14. Biopharmaceutical Testing Services Report Years Considered

Figure 15. Global Biopharmaceutical Testing Services Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 16. Global Biopharmaceutical Testing Services Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 17. Global Biopharmaceutical Testing Services Market Share by Region: 2025 vs 2032

Figure 18. Global Biopharmaceutical Testing Services Market Share by Players in 2025

Figure 19. Global Biopharmaceutical Testing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 20. The Top 10 and 5 Players Market Share by Biopharmaceutical Testing Services Revenue in 2025

Figure 21. North America Biopharmaceutical Testing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. North America Biopharmaceutical Testing Services Market Share by Country (2021–2032)

Figure 23. United States Biopharmaceutical Testing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Canada Biopharmaceutical Testing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Europe Biopharmaceutical Testing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. Europe Biopharmaceutical Testing Services Market Share by Country (2021–2032)

Figure 27. Germany Biopharmaceutical Testing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. France Biopharmaceutical Testing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. U.K. Biopharmaceutical Testing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Italy Biopharmaceutical Testing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Russia Biopharmaceutical Testing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Ireland Biopharmaceutical Testing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Asia-Pacific Biopharmaceutical Testing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Asia-Pacific Biopharmaceutical Testing Services Market Share by Region (2021–2032)

Figure 35. China Biopharmaceutical Testing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Japan Biopharmaceutical Testing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. South Korea Biopharmaceutical Testing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Southeast Asia Biopharmaceutical Testing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. India Biopharmaceutical Testing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Australia & New Zealand Biopharmaceutical Testing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Latin America Biopharmaceutical Testing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Latin America Biopharmaceutical Testing Services Market Share by Country (2021–2032)

Figure 43. Mexico Biopharmaceutical Testing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Brazil Biopharmaceutical Testing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Middle East & Africa Biopharmaceutical Testing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Middle East & Africa Biopharmaceutical Testing Services Market Share by Country (2021–2032)

Figure 47. Israel Biopharmaceutical Testing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Saudi Arabia Biopharmaceutical Testing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. UAE Biopharmaceutical Testing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Eurofins Scientific Revenue Growth Rate in Biopharmaceutical Testing Services Business (2021–2026)

Figure 51. SGS Revenue Growth Rate in Biopharmaceutical Testing Services Business (2021–2026)

Figure 52. Envigo Revenue Growth Rate in Biopharmaceutical Testing Services Business (2021–2026)

Figure 53. Exova Group Revenue Growth Rate in Biopharmaceutical Testing Services Business (2021–2026)

Figure 54. PPD Inc. Revenue Growth Rate in Biopharmaceutical Testing Services Business (2021–2026)

Figure 55. Pace Analytical Services Revenue Growth Rate in Biopharmaceutical Testing Services Business (2021–2026)

Figure 56. Intertek Group Revenue Growth Rate in Biopharmaceutical Testing Services Business (2021–2026)

Figure 57. DYNALABS Revenue Growth Rate in Biopharmaceutical Testing Services Business (2021–2026)

Figure 58. RD Laboratories Revenue Growth Rate in Biopharmaceutical Testing Services Business (2021–2026)

Figure 59. West Pharmaceutical Services Revenue Growth Rate in Biopharmaceutical Testing Services Business (2021–2026)

Figure 60. Polymer Solutions Revenue Growth Rate in Biopharmaceutical Testing Services Business (2021–2026)

Figure 61. Boston Analytical Revenue Growth Rate in Biopharmaceutical Testing Services Business (2021–2026)

Figure 62. Accuratus Labs Revenue Growth Rate in Biopharmaceutical Testing Services Business (2021–2026)

Figure 63. Microbac Revenue Growth Rate in Biopharmaceutical Testing Services Business (2021–2026)

Figure 64. ARLBioPharma Revenue Growth Rate in Biopharmaceutical Testing Services Business (2021–2026)

Figure 65. Lapuck Laboratories Revenue Growth Rate in Biopharmaceutical Testing Services Business (2021–2026)

Figure 66. BioScreen Revenue Growth Rate in Biopharmaceutical Testing Services Business (2021–2026)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Biopharmaceutical Testing Services market? zhanKai

The top companies in the global Biopharmaceutical Testing Services market are Eurofins Scientific、SGS、Envigo.

Related Reports

Biopharmaceutical Testing Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Biopharmaceutical Testing Services was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 121
USD 3950.00
(Single User License)
Global Biopharmaceutical Testing Services Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Biopharmaceutical Testing Services market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 153
USD 4900.00
(Single User License)
Global Biopharmaceutical Testing Services Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Biopharmaceutical Testing Services market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 101
USD 4250.00
(Single User License)
Biopharmaceutical Testing Services- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Biopharmaceutical Testing Services was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 139
USD 3950.00
(Single User License)
Global Biopharmaceutical Testing Services Market Research Report 2025
The global market for Biopharmaceutical Testing Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-20
Pages: 95
USD 2900.00
(Single User License)
Global Biopharmaceutical Testing Services Market Insights, Forecast to 2030
Biopharmaceutical testing is a critical step in the development of a biosimilar. Analytical testing provides the information needed to produce a safe and effective biopharmaceutical product, and the efficacy or safety depends on a product’s critical quality attributes (CQA). Biopharmaceutical testing involves the development, validation, and execution of wide-ranging cGMP analytical strategies, from routine tests to the application of state-of-the-art instrumental analysis, such as mass spectrometry.
Published Date: 2024-04-19
Pages: 113
USD 4900.00
(Single User License)
Global Biopharmaceutical Testing Services Market Research Report 2024
Biopharmaceutical testing is a critical step in the development of a biosimilar. Analytical testing provides the information needed to produce a safe and effective biopharmaceutical product, and the efficacy or safety depends on a product’s critical quality attributes (CQA). Biopharmaceutical testing involves the development, validation, and execution of wide-ranging cGMP analytical strategies, from routine tests to the application of state-of-the-art instrumental analysis, such as mass spectrometry.
Published Date: 2024-01-17
Pages: 90
USD 2900.00
(Single User License)
Biopharmaceutical Testing Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Biopharmaceutical testing is a critical step in the development of a biosimilar. Analytical testing provides the information needed to produce a safe and effective biopharmaceutical product, and the efficacy or safety depends on a product’s critical quality attributes (CQA). Biopharmaceutical testing involves the development, validation, and execution of wide-ranging cGMP analytical strategies, from routine tests to the application of state-of-the-art instrumental analysis, such as mass spectrometry.
Published Date: 2024-01-06
Pages: 131
USD 3950.00
(Single User License)

Biopharmaceutical Testing Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Biopharmaceutical Testing Services was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 121
USD 3950.00 (Single User License)
Global Biopharmaceutical Testing Services Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Biopharmaceutical Testing Services market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 153
USD 4900.00 (Single User License)
Global Biopharmaceutical Testing Services Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Biopharmaceutical Testing Services market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 101
USD 4250.00 (Single User License)
Biopharmaceutical Testing Services- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Biopharmaceutical Testing Services was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 139
USD 3950.00 (Single User License)
Global Biopharmaceutical Testing Services Market Research Report 2025
The global market for Biopharmaceutical Testing Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-20
Pages: 95
USD 2900.00 (Single User License)
Global Biopharmaceutical Testing Services Market Insights, Forecast to 2030
Biopharmaceutical testing is a critical step in the development of a biosimilar. Analytical testing provides the information needed to produce a safe and effective biopharmaceutical product, and the efficacy or safety depends on a product’s critical quality attributes (CQA). Biopharmaceutical testing involves the development, validation, and execution of wide-ranging cGMP analytical strategies, from routine tests to the application of state-of-the-art instrumental analysis, such as mass spectrometry.
Published: 2024-04-19
Pages: 113
USD 4900.00 (Single User License)
Global Biopharmaceutical Testing Services Market Research Report 2024
Biopharmaceutical testing is a critical step in the development of a biosimilar. Analytical testing provides the information needed to produce a safe and effective biopharmaceutical product, and the efficacy or safety depends on a product’s critical quality attributes (CQA). Biopharmaceutical testing involves the development, validation, and execution of wide-ranging cGMP analytical strategies, from routine tests to the application of state-of-the-art instrumental analysis, such as mass spectrometry.
Published: 2024-01-17
Pages: 90
USD 2900.00 (Single User License)
Biopharmaceutical Testing Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Biopharmaceutical testing is a critical step in the development of a biosimilar. Analytical testing provides the information needed to produce a safe and effective biopharmaceutical product, and the efficacy or safety depends on a product’s critical quality attributes (CQA). Biopharmaceutical testing involves the development, validation, and execution of wide-ranging cGMP analytical strategies, from routine tests to the application of state-of-the-art instrumental analysis, such as mass spectrometry.
Published: 2024-01-06
Pages: 131
USD 3950.00 (Single User License)